Ignite Creation Date:
2024-05-06 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06161532
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2023-12-02
Brief Title:
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors SMART Such as Small Cell Adenocarcinoma and Squamous Cell BladderUrinary Tract Cancer Renal Medullary Carcinoma and Penile Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-02
First Submit QC Date:
December 7 2023
Study First Post Date:
2023-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-06
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED